Fully Bioresorbable Coronary Drug-Eluting Stent System
The AMSorb® stent is a new generation of degradable vascular drug-eluting stent manufactured by the proprietary MASE technology. The product has entered the national special review channel for innovative medical devices, and the product is currently undergoing RCT trials.
If you want to get more product information, welcome to contact us
Fully Bioresorbable Coronary Drug-Eluting Stent System
Graphic Details
The AMSorb® stent is a new generation of degradable vascular drug-eluting stent manufactured by Mutli-Axial Scaffold Extrusion (MASE) technology developed by AMET. The product has been approved to enter the national special regulatory review pathway for innovative medical devices and is currently undergoing the registration clinical trials (RCT).
Product Features
● New stent manufacturing process with controlled material crystallinity for faster degradation rate
● Patented closed-cell stent design with excellent radial strength and structural stability
● Better stent crossing and delivery performances due to the flexible stent design
● Round stent struts with reduced cross-sectional areas for faster endothelialization and material resorption
Specifications
Stent diameter: 2.5mm~4.0mm
Stent length: 12mm~33mm
Results of AMSorb® FIM Trial 3 Years Follow-up: Restore, Repair and Resorption
Contact Us
Address: Building 11, Zhongguancun Medical Equipment Park, No. 26, Yongwang West Road, Daxing District, Beijing
Tel：010-6297-7955 E-Mail：amt@ametcorp.com
WeChat Contact
@Copyright 2022 Beijing Advanced Medical Technologies, Inc. All rights reserved
京ICP备11028039号 Powered by: www.300.cn SEO